Mechanisms of Response and Resistance to AML Therapies.

Mechanisms of Response and Resistance to AML Therapies. Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S7 Authors: Stoilova B, Moore R, Metzner M, Zheng Z, Konopleva M, DiNardo C, Vyas P PMID: 32862876 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32862876?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - August 31, 2020 Category: Cancer & Oncology Authors: Stoilova B, Moore R, Metzner M, Zheng Z, Konopleva M, DiNardo C, Vyas P Tags: Clin Lymphoma Myeloma Leuk Source Type: research

More News: Cancer & Oncology | Lymphoma | Myeloma